U.S. Senate negotiators near agreement on $10 billion round of COVID
funds
Send a link to a friend
[April 01, 2022]
By Richard Cowan
WASHINGTON (Reuters) - U.S. Senate
negotiators on Thursday were nearing a deal on a $10 billion COVID-19
bill to help the federal government acquire more vaccines and medical
supplies as it prepares for future variants of the virus that upended
American life.
Senate Majority Leader Chuck Schumer, a Democrat, said senators were
"close to a final agreement" on a bill aiming to shore up stockpiles to
be used both domestically and internationally.
If a deal is finalized in coming days, the Senate might be able to pass
the bill and send it to the House of Representatives before the start of
a spring recess at the end of next week.
"We need more money right away so we have enough vaccines and testing
and life-saving therapeutics," Schumer said in a speech to the Senate.
The amount is a tiny fraction of the $4.6 trillion Congress has approved
since early 2020 to fight the virus, much of which was devoted to
offsetting its heavy economic hit.
Early this month, Congress failed to pass a $15.6 billion relief bill
amid Republican opposition to new federal spending. Many Democrats,
meanwhile, rebelled against taking back some money earmarked to help
state and local governments in order to pay for the new round of coronavirus relief.
[to top of second column]
|
U.S. Senate Majjority Leader Chuck Schumer (D-NY) faces reporters
following the weekly Senate Democratic lunch on Capitol Hill in
Washington, U.S., March 29, 2022. REUTERS/Evelyn Hockstein
Schumer said a failure to adequately
prepare for a possible new coronavirus variant could reverse
progress in fighting the pandemic and reopening most American
institutions.
Republican Senator Roy Blunt told reporters that nearly half of the
financing for the bill would come from recapturing funding from
previous COVID aid laws that were intended to help performing arts
venues recover from being shuttered during long periods of the
pandemic and for aid to aviation manufacturers.
COVID-19 has caused 6.5 million deaths globally, with 980,000 in the
United States alone. While the pandemic has been showing signs of
easing, prompting many to shed the medical masks that had become
part of daily life, U.S. deaths still lead the world with an average
of 710 per day.
(Reporting by Richard Cowan; Editing by Scott Malone and David
Gregorio)
[© 2022 Thomson Reuters. All rights
reserved.] This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
|